We compare aequorin, alkaline phosphatase and horseradish peroxidase as reporters for luminescent immunoassays using -fetoprotein (AFP) as a model analyte. Biotinylated aequorin was prepared from mutated aequorin containing a reactive cysteine residue by chemical conjugation. The measurable range of AFP using this biotinylated aequorin was 0.02-200 ng/ml, with a lower background level than the other biotinylated enzymes tested.
Aequorin is a Ca
2þ -binding photoprotein that is highly sensitive to Ca 2þ and has been used as a biological Ca 2þ indicator. The luminescence reaction of aequorin is fast (within a few seconds) which is simply initiated by the addition of Ca 2þ . 1, 2) In 1985, we isolated the cDNA of aequorin (GenBank Accession no. L29571) from the luminous jellyfish, Aequorea victoria.
3) The apoprotein of aequorin (apoaequorin) was expressed in Escherichia coli 4, 5) and highly purified recombinant aequorin was obtained. 6) The crystal structure analysis of recombinant aequorin 7) and of semi-synthetic aequorins 8) revealed aequorin to be a non-covalent complex of 2-hydroperoxycoelenterazine and apoaequorin and to have three EF-hand structures characteristic of Ca 2þ -binding sites. Furthermore, NMR analysis of recombinant aequorin under various concentrations of Mg 2þ suggested that the binding affinity of Ca 2þ to the three EF-hand domains might be different among them.
9) The applications of aequorin have been reported in various assay systems including immunoassays, [10] [11] [12] [13] [14] [15] enzyme assays 16, 17) and hybridization assays. 18, 19) Recently, we prepared a variant of recombinant aequorin which contains a reactive cysteine residue (assigned ''Cys-aequorin'') 20) and applied it as an antibody label for immunoassays. 20, 21) The sandwich immunoassay using the streptavidinbiotin complex is the most popular technique for detecting an antigen using biotinylated enzymes such as alkaline phosphatase and horseradish peroxidase as reporters (Fig. 1A ). More recently, biotinylated aequorin has been used as a reporter. Biotinylated aequorin can be prepared by either chemical conjugation 12, 22, 23) or recombinant DNA technology by co-expressing the fused protein of apoaequorin with the biotin-acceptor domain of the biotin carboxy carrier protein as well as the bacterial biotin protein ligase in E. coli. 24) In the first case, native and mutated recombinant apoaequorins have been chemically biotinylated with succinimidyl biotin derivatives and then regenerated to biotinylated aequorin by incubation with coelenterazine. However, the luminescence recovery of aequorin was low. 11, 12, 22) To improve the luminescence activity of biotinylated aequorin, we have prepared biotinylated aequorin using the purified recombinant aequorin and succinimidyl 6-(biotinamido)hexanoate and demonstrated no significant loss of luminescence activity.
23) The conjugation ratio of aequorin and biotin was estimated to 1.0:2.3 by matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). 23) To apply Cysaequorin 20) to a bioluminescent sandwich immunoassay using the streptavidin-biotin complex, we prepared biotinylated Cys-aequorin (AQ-S-biotin) by conjugating Cys-aequorin with the maleimide-activated biotin (see below). The feasibility of biotinylated aequorin for use in a bioluminescent immunoassay was evaluated by using -fetoprotein (AFP), a serological marker of liver cancer as a model analyte, and was compared to two commonly used chemiluminescent reporters, biotinylated alkaline phosphatase (AP-biotin) and biotinylated horseradish peroxidase (HRP-biotin) (Fig. 1) .
To prepare AQ-S-biotin, (þ)-biotinyl-3-maleimidopropionamidyl-3,6-dioxaoctanediamine (PEO-maleimide activated biotin; Pierce Biotechnology, Rockford, IL, USA) was used. Briefly, Cys-aequorin (292 mg, y To whom correspondence should be addressed. Tel: +81-45-786-5518; Fax: +81-45-786-5512; E-mail: sinouye@chisso.co.jp Abbreviations: AFP, -fetoprotein; Cys-aequorin, mutated aequorin with a reactive cysteine residue; AQ-S-biotin, biotinylated Cys-aequorin; AQ-N-biotin, biotinylated aequorin; AP-biotin, biotinylated alkaline phosphatase; HRP-biotin, biotinylated horseradish peroxidase; MALDI-TOF-MS, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; CV, coefficient of variation; r, correlation coefficient; SD, standard deviation 13.6 nmol) dissolved in 800 ml of 66 mM phosphate buffer (pH 7.4) containing 0.1 mM EDTA (Buffer A) was incubated with 4 ml of 10 mM PEO-maleimide activated biotin (40 nmol) at 20 C for 2 h. After conjugation, the mixture was washed three times with 1.5 ml of Buffer A, using a Centricon-10 filter (Millipore, Mw cutoff: 10,000) at 5; 000 g. AQ-S-biotin obtained was stored in 50 mM Tris-HCl (pH 7.6) containing 0.1% bovine serum albumin (Fraction V, Seikagaku Co., Japan) containing 10 mM EDTA and was stable over 3 years at À80
C. The biotinylation of Cysaequorin was determined with MALDI-TOF-MS analysis. The mass value of m=z 22253.1 for [M + H] þ was observed and was close to the calculated average mass value of 22255.8 for AQ-S-biotin. The purity of AQ-Sbiotin was estimated to be over 95% by calculating the peak intensity of mass values (data not shown). The luminescent recovery of AQ-S-biotin was 90.2%. The biotinylated anti-AFP antibody 1D5 (sodium azide-free, Japan Clinical Lab., Kyoto, Japan) was prepared by using succinimidyl-6-(biotinamido)hexanoate (NHS-LC-biotin; Pierce Biotechnology). Anti-AFP antibody 1D5 (543 mg, 3.62 nmol) dissolved in 300 ml of Buffer A was incubated with 10 ml of 10 mM NHS-LC-biotin (100 nmol) at 4 C for 18 h. After washing with 1 ml of Buffer A using Centricon-30, the biotinylated antibody was obtained quantitatively, as estimated by the absorbance at 280 nm.
The bioluminescent sandwich immunoassay for AFP with the streptavidin-biotin complex was performed as follows. The streptavidin AQ-S-biotin complex was prepared by mixing AQ-S-biotin (100 ng/ml, 4.6 pmol) and streptavidin (137 ng/ml, 2.3 pmol; Wako Pure Chemicals, Osaka, Japan) at 1:0.5 ratio. The anti-AFP antibody 6D2 (100 ml of 5 mg/ml; Japan Clinical Lab.) used as the capturing antibody was diluted in 50 mM sodium bicarbonate buffer (pH 9.5) and added to the wells of a 96-well white plate (Nunc, cat. no. 236108) and then incubated for 18 h at 30 C. After washing away the non-adsorbed 6D2 antibody, the wells were blocked with 200 ml of 1% bovine serum albumin in 20 mM Tris-HCl (pH 7.6)-150 mM NaCl (TBS) containing 2 mM EDTA and 0.05% NaN 3 for 18 h at 4 C. The wells were then washed three times with 340 ml of TBS containing 0.05% (v/w) Tween 20 (Bio-Rad) and 2 mM EDTA (TBST-E). A series of AFP solutions (20 pg/ml to 200 ng/ml), as well as the biotinylated anti-AFP antibody, were diluted with TBS containing 10% (v/w) Block Ace (Dainippon Pharmaceutical Co., Osaka, Japan), 5 mM EDTA and 0.05% Tween 20. Fifty microliters of each AFP solution was added to anti-AFP 6D2 coated wells, followed by 50 ml of the biotinylated anti-AFP antibody 1D5 (74.5 ng/ml). After incubating at 30 C for 1 h, the wells were washed three times with 340 ml of TBST-E. The streptavidin-biotinylated aequorin complex (1.8 ng of biotinylated aequorin/ well) was added and further incubated at 30 C for 30 min. The wells were washed three times with 340 ml of TBST-E and the luminescence intensity of aequorin was measured by injecting 100 ml of 50 mM CaCl 2 in 50 mM Tris-HCl (pH 7.6), using a Centro 960 luminometer from Berthold Technologies (Bad Wildbad, Germany) equipped with a 9124B photomultiplier (Electron Tube, UK). The luminescence activity was determined by integrating for 1 sec in 0.1-sec intervals.
To compare biotinylated aequorin with the other chemiluminescent reporters, AP-biotin (Vector Lab., Burlingame, CA, USA) and HRP-biotin (Vector Lab.) from Vectastain ABC kit were used. The assay procedures and materials used were similar to those for the aequorin bioluminescent immunoassay. The chemiluminescence substrates used for alkaline phosphatase (AP) and horseradish peroxidase (HRP) were CDP-star (Applied Biosystems, Bedford, MA, USA) and Femtoglow (Michigan Diagnostics, Troy, MI, USA), respectively, and the assay procedure was carried out according to the manufacturer's protocol. The concentrations of biotinylated AP and biotinylated HRP used were 0.6 ng of biotinylated enzymes per well, as estimated by the luminescence activity. After incubation with enhancer/substrate solution for 30 min at room temperature, the chemiluminescence intensity was measured with a Centro 960 luminometer by integration for 1 sec in 0.1-sec intervals.
The relationship between the amount of biotinylated aequorin (AQ-S-biotin) and the luminescence intensity was investigated, and the results were compared with those for non-labeled recombinant aequorin. The luminescence intensity of AQ-S-biotin was proportional to the amount of each protein in a range covering over 10,000-fold. Under our assay conditions, the linearity of luminescence for AQ-S-biotin ranged from 1 fg/well to 100 pg/well, similar to that for non-labeled aequorin (data not shown). The sensitivity of the AQ-S-biotin reporter for immunoassays was compared with that of the AP-biotin and HRP-biotin chemiluminescent reporters by using the streptavidin-biotin complex system and AFP as a model analyte (Fig. 1A) . The luminescence values greater than the blank value plus 3SD (blank + 3SD) were taken to be significant, and the coefficient of variation (%CV, n ¼ 6) for each AFP concentration was calculated. The measurable range of AFP using AQ-Sbiotin was 0.02-200 ng/ml, which is similar to that for AP-biotin and HRP-biotin (Fig. 1B) . These results were correlated with the use of the aequorin-labeled antibody, AQ-S-Ab1D5, with the same detection range for AFP. 20) The average CV values for AQ-S-biotin, AP-biotin, HRP-biotin and AQ-S-Ab1D5 were 2.4, 6.3, 4.8 and 3.6%, respectively ( Table 1) . The correlation coefficient (r) for AQ-S-biotin was over 0.999. However, the background signal of aequorin luminescence was 5 to 10 times lower than that of AP-biotin or HRP-biotin (Fig. 1B) . The other biotinylated aequorin with succinimidyl-6-(biotinamido)hexanoate (AQ-N-biotin) 23 ) was also examined under the same conditions. The results show that AQ-N-biotin could be used for immunoassay and the detection range of 0.02-200 ng/ml is similar to that of AQ-S-biotin with similar luminescence intensity.
From the above results, we concluded that biotinylated aequorin could be easily applied to a bioluminescent immunoassay with similar sensitivity of chemiluminescent immunoassays using alkaline phosphatase or horseradish peroxidase as a label. 
